Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LIVEPERSON INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
223
219
250
292
367
470
515
402
312
244
Cost of revenue
63.2
58.2
62.5
78.9
106
157
185
116
77.4
69.4
Gross profit
160
161
187
213
260
313
330
286
235
174
Research and development
40.2
40
55.7
82.1
108
158
194
104
79.8
54.7
Selling and marketing
89.5
90.9
103
157
150
165
214
123
97.3
75.8
General and administrative
43
43.1
45.9
57
60.6
76.8
121
91.2
79.8
44.4
Operating income
-19.4
-17.8
-23.7
-87
-89.5
-93.3
-222
-111
-183
-78.7
Interest expense
10
14.6
37.5
5.5
4.88
14.5
31.5
Interest income
5.15
9.55
5.86
4.75
Other non-operating income
-0.53
0.14
-0.47
-6.19
-15.7
-34.1
-2.14
15.1
51.7
14.9
Pre-tax income
-19.9
-17.7
-24.2
-93.2
-105
-128
-220
-95.8
-126
-59.5
Income tax
5.93
0.5
0.86
2.85
2.47
-2.4
1.73
4.16
2.74
3.45
Net income
-25.9
-18.2
-25
-96.1
-108
-125
-226
-100
-134
-67.2
EBITDA
-7.4
-5.47
-9.52
-70.7
-66.6
-65.8
-190
-56.6
-141
-56
EPS, basic
-6.89
-4.79
-6.29
-22.91
-24.41
-26.96
-45.38
-19.17
-22.70
-8.57
EPS, diluted
-6.89
-4.79
-6.29
-22.91
-24.41
-26.96
-45.38
-19.17
-22.70
-12.39
Shares, basic (weighted)
3.74
3.76
3.95
4.18
4.4
4.65
4.98
5.24
5.91
7.84
Shares, diluted (weighted)
3.74
3.76
3.95
4.18
4.4
4.65
4.98
5.24
5.91
8.64
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
50.9
56.1
66.4
177
654
522
392
211
183
95
Receivables
31.8
37.9
46
87.6
80.4
93.8
86.5
81.8
28.7
27
Other current assets
5.48
7.35
9.25
14
14.2
20.6
4.2
8.76
4.02
1.48
Total current assets
92.2
103
122
278
749
636
533
322
231
137
Property, plant and equipment
28.4
34.7
43.7
76.2
106
125
138
119
101
90.4
Lease right-of-use assets
15.7
0.61
1.98
1.6
4.14
0.05
Goodwill
80.2
80.5
95
95
95.2
291
296
286
223
185
Intangible assets
16.5
12.4
13.8
11.8
10.9
85.6
78.1
61.6
15.1
13.4
Other non-current assets
1.56
1.6
1.71
1.74
1.78
1.2
2.56
1.21
0.4
0.39
Total assets
220
233
290
513
1,006
1,187
1,089
836
608
455
Accounts payable
7.29
5.48
8.17
12.3
14.1
16.9
25.3
13.6
15.4
9.52
Accrued liabilities
40.3
48
50.7
62.8
99.9
104
129
97
66.6
38.7
Deferred revenue
27.1
35.6
55
88.8
88.8
98.8
84.5
81.9
58
54.3
Short-term debt
0
72.4
Total current liabilities
74.7
89.1
114
170
209
223
252
268
140
123
Lease liabilities
12.9
7.18
2.73
0.68
2.17
0
Other non-current liabilities
3.15
2.77
4.21
0.07
6.3
34.7
28.6
3.16
4.54
0.67
Total liabilities
81.2
92.7
119
364
762
837
1,021
787
675
499
Total debt
538
574
737
512
Paid-in capital
290
306
363
437
636
872
771
914
936
1,021
Retained earnings
-145
-163
-187
-284
-392
-517
-692
-857
-991
-1,058
Treasury stock
-0
-0
-0
-0
-0
-0
-0
-0
-0
-0
Other comprehensive income
-6.16
-2.54
-4.43
-4.52
0.08
-5.56
-10.7
-8.48
-12.2
-7.25
Shareholders' equity
138
140
171
149
244
349
68.1
48.1
-67.3
-44.5
Total equity
138
140
171
149
244
349
68.1
48.1
-67.3
-44.5
Total liabilities and equity
220
233
290
513
1,006
1,187
1,089
836
608
455
Shares outstanding
3.89
3.98
4.07
4.26
4.51
4.82
5.05
87.8
6.08
12
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-25.9
-18.2
-25
-96.1
-108
-125
-226
-100
-134
-67.2
Depreciation and amortization
12
12.4
14.2
16.4
22.8
27.4
32.3
54.8
42.3
22.7
Stock-based compensation
9.74
8.94
14.8
44.1
65.9
69.7
110
11.9
22
14.3
Deferred income tax
1.85
-2.4
-0.31
-1.21
0.58
-6.24
-1.16
1.05
0.62
0.62
Change in receivables
-3.27
-8
-9.66
-43.8
6.37
-17.3
-0.04
1.46
37.5
1.16
Change in payables
0.19
-2.74
2.2
3.81
-0.73
0.8
12.1
-13.6
Cash from operations
24.6
10.3
4.78
-59.2
33.6
3.25
-62.1
-19.8
-15.1
-30.4
Capital expenditures
-12.3
-17.4
-21.9
-47.6
-41.6
-45.7
-48.5
-28.7
-25.1
-12.1
Acquisitions
0
0
-70.8
-3.43
0
0
Cash from investing
-11.5
-15.3
-27.8
-48.5
-43.5
-140
-56.9
-18.8
-28.2
-13.7
Stock issued
2.9
8.95
35.3
21.1
25.4
16.1
5.57
1.89
0.35
0.82
Share buybacks
-9.97
-1.74
-1.35
-0.9
0
-0.71
-0.22
0
0
Cash from financing
-7.07
7.21
33.9
218
484
11.8
1.62
-151
15
-45.5
Exchange rate effect
-3.95
3.05
-0.6
-0.11
3.66
-5.46
-3.98
0.47
-1.31
1.43
Net change in cash
2.09
5.23
10.3
110
478
-131
-121
-189
-29.7
-88.2
Free cash flow
12.2
-7.1
-17.2
-107
-8.04
-42.5
-111
-48.4
-40.3
-42.5
Interest paid
0
0.85
1.93
2.09
1.93
1.24
3.71
9.22
Income taxes paid
0.42
1.55
5.14
3.3
4.65
0.58
3.24
1.86
1.89
1.21
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.10 on September 3, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
71.8%
Gross profit / revenue.
Operating margin
-54.5%
Operating income / revenue.
EBITDA margin
-45.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-51.9%
Net income / revenue.
FCF margin
-6.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-2.1%
Cash from operations / revenue.
Return on assets (ROA)
-30.9%
Net income / average total assets.
R&D / revenue
20.7%
Research and development expense / revenue.
Stock-based pay / revenue
4.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
4.5%
Capital expenditures / revenue.
D&A / revenue
9.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-22.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-22.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-7.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-25.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-19.2%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-7.7%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-25.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-25.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-14.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
46.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
20.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
14.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.10x
Current assets / current liabilities.
Quick ratio
0.97x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.82x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$18.71
Revenue / diluted weighted shares.
FCF per share
-$1.24
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.40
Cash from operations / diluted weighted shares.
Book value per share
-$9.89
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.17x
Market cap / revenue.
FCF yield
-39.8%
Free cash flow / market cap.
Earnings yield
-310.6%
Net income / market cap (the inverse of P/E).
What was LIVEPERSON INC's revenue in fiscal 2025?
LIVEPERSON INC reported revenue of $243.7M for fiscal 2025, 22% lower than the year before.
Was LIVEPERSON INC profitable in fiscal 2025?
No. It reported a net loss of $67.2M.
How much free cash flow did LIVEPERSON INC generate in fiscal 2025?
Cash from operations of $30.4M minus capital expenditures of $12.1M left free cash flow of -$42.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.